Parameters | Total (n = 66) | AKI (n = 35) | Non AKI (n = 31) | P |
---|---|---|---|---|
Baseline Characteristics | ||||
Age, years | 7.2 ± 3.8 | 6.9 ± 4.0 | 7.5 ± 3.8 | 0.53 |
Male gender, n (%) | 33 (50) | 16 (45.7) | 17 (54.8) | 0.46 |
BMI | 14.2 ± 2.1 | 14.1 ± 2.2 | 14.3 ± 2.1 | 0.75 |
New onset DKA, n(%) | 41 (62.1) | 23 (65.7) | 18 (58.1) | 0.06 |
Duration of diabetes, months, Median (IQR) | 17(8, 40) | 30 (8, 45) | 17 (8, 33) | 0.62 |
Duration of prodrome, days, Median (IQR) | 5 (2,10) | 3 (2,7) | 7 (4,10) | 0.09 |
GCS, Median(IQR) | 13 (11,15) | 12 (10,14) | 15 (12,15) | 0.005 |
Severity of DKA | ||||
Mild and moderate, n(%) | 26 (39.4) | 7 (20) | 19 (61.3) | 0.001 |
Severe, n(%) | 40 (60.6) | 28 (80) | 12 (38.7) | |
Lab values at presentation | ||||
Glucose at 0 h, mg/dl | 487 ± 151 | 523 ± 156 | 445 ± 135 | 0.07 |
Glucose at 1 h, mg/dl | 447 ± 151 | 476 ± 146 | 415 ± 106 | 0.09 |
Blood Ketones, mmol/L | 5.5 ± 1.0 | 5.4 ± 0.9 | 5.6 ± 1.0 | 0.20 |
pH | 7.02 ± 0.15 | 6.97 ± 0.12 | 7.08 ± 0.15 | 0.002 |
Bicarbonate, mmol/L | 7.4 ± 2.5 | 6.9 ± 2.4 | 7.8 ± 2.5 | 0.06 |
Sodium, mmol/L | 138 ± 6.9 | 139 ± 7.6 | 136 ± 6.1 | 0.33 |
Corrected sodium, mmol/L | 144 ± 6.9 | 145 ± 7.7 | 142 ± 5.5 | 0.08 |
Chloride, mmol/L | 112 ± 8.8 | 112 ± 10.5 | 111 ± 7.1 | 0.87 |
Potassium, mmol/L | 4.0 ± 0.89 | 4.3 ± 0.9 | 3.7 ± 0.7 | 0.02 |
Anion gap, mmol/L | 19.9 ± 5.1 | 20.4 ± 5.3 | 19.4 ± 5.0 | 0.51 |
Osmolality, mmol/kg | 301 ± 15 | 306 ± 16 | 295 ± 12 | 0.0001 |
Phosphate, mmol/L | 2.7 ± 0.98 | 2.7 ± 0.9 | 2.7 ± 1.1 | 0.84 |
HbA1C, % | 12.5 ± 2.4 | 12.6 ± 2.5 | 12.3 ± 2.6 | 0.63 |
Fluid therapy | ||||
Fluids received, ml/kg [Median (IQR)] | 66 (46,100) | 80 (55, 103) | 58 (37,93) | 0.04 |
Urine output, ml/kg/hr | 2.9 (2.2,3.5) | 2.7 (2.0,3.5) | 3.0 (2.5, 3.8) | 0.54 |
Creatinine, mg/dl | ||||
0 h | 0.85 ± 0.43 | 1.1 ± 0.41 | 0.55 ± 0.17 | < 0.0001 |
24 h | 0.56 ± 0.44 | 0.68 ± 0.57 | 0.42 ± 0.14 | 0.002 |
48 h | 0.49 ± 0.44 | 0.6 ± 0.5 | 0.35 ± 0.11 | 0.001 |
uNGAL, ng/ml | ||||
0 h | 67.8 ± 27.7 | 79.8 ± 27.2 | 54.6 ± 22.0 | 0.0002 |
24 h | 24.2 ± 20.2 | 61.4 ± 28.3 | 20.2 ± 14.5 | 0.0003 |
Decline over 24 h (%) | 62.3 ± 25.9 | 21.5 ± 17.0 | 66.8 ± 21.7 | 0.0003 |
uNCR, ng/mg | ||||
0 h | 5.4 ± 3.4 | 6.7 ± 3.7 | 4.1 ± 2.6 | 0.002 |
24 h | 2.8 ± 1.7 | 6.3 ± 2.5 | 1.2 ± 1.0 | 0.01 |
Decline over 24 h (%) | 71.0 ± 25.5 | 59.8 ± 38.4 | 74.7 ± 16.08 | 0.04 |
Outcome | ||||
Duration to achieve end points, hours | 15.0 ± 7.1 | 16.4 ± 7.1 | 13.6 ± 7.0 | 0.11 |
Length of PICU stay, hours | 48 ± 21 | 52 ± 24 | 42 ± 17 | 0.17 |
Length of Hospital stay, days | 10 ± 4.6 | 10 ± 4.8 | 10 ± 4.4 | 0.93 |